Literature DB >> 23408393

Effect of longitudinal changes in visceral fat area on incidence of metabolic risk factors: the Hitachi health study.

Yumi Matsushita1, Toru Nakagawa, Shuichiro Yamamoto, Yoshihiko Takahashi, Tetsuji Yokoyama, Tetsuya Mizoue, Mitsuhiko Noda.   

Abstract

OBJECTIVE: To examine the incidences of metabolic risk factors according to changes in visceral fat area (VFA) in a large Japanese population. DESIGN AND METHODS: The subjects were 973 men who received a computed tomography (CT) examination in health checkups twice (2004-2005 and 2007-2008), and not having two or more of metabolic risk factors (except for the waist circumference) in 2004-2005. VFA was measured using CT. To assess the potential influence of changes in VFA for the 3-year incidences of each metabolic risk factor and clustering metabolic risk factors, logistic regression analyses were used.
RESULTS: A significant association was observed between the change in VFA and the components of the metabolic risk factors. Incidences of the components of the metabolic risk factors were significantly higher among subjects with a larger increase in VFA and were significantly lower among subjects with a larger decrease in VFA (trend P < 0.001). Significant increases in the odds ratios for the incidences of high triglycerides and low high-density lipoprotein cholesterol level were observed among subjects with ≥50 cm(2) VFA increase.
CONCLUSIONS: The adoption of a lifestyle that does not increase the VFA is important for preventing metabolic syndrome.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Year:  2013        PMID: 23408393     DOI: 10.1002/oby.20347

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  7 in total

1.  Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.

Authors:  Ravi V Shah; Venkatesh L Murthy; Siddique A Abbasi; Ron Blankstein; Raymond Y Kwong; Allison B Goldfine; Michael Jerosch-Herold; João A C Lima; Jingzhong Ding; Matthew A Allison
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-05

2.  Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.

Authors:  Su Hwan Kim; Hyoun Woo Kang; Ji Bong Jeong; Dong Seok Lee; Dong-Won Ahn; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Sohee Oh; Soon Ho Yoon; Sang Joon Park
Journal:  PLoS One       Date:  2021-08-17       Impact factor: 3.240

3.  Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.

Authors:  Jane J Lee; Alison Pedley; Udo Hoffmann; Joseph M Massaro; Caroline S Fox
Journal:  J Am Coll Cardiol       Date:  2016-10-04       Impact factor: 24.094

4.  Changes in central adipose tissue after switching to integrase inhibitors.

Authors:  Paula Debroy; Han Feng; Hongyu Miao; Jovana Milic; Guido Ligabue; Stefano Draisci; Giulia Besutti; Federica Carli; Marianna Menozzi; Cristina Mussini; Giovanni Guaraldi; Jordan E Lake
Journal:  HIV Res Clin Pract       Date:  2021-01-18

5.  Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study.

Authors:  Leonardo S Roever; Elmiro S Resende; Angélica L D Diniz; Nilson Penha-Silva; Fernando C Veloso; Antonio Casella-Filho; Paulo M M Dourado; Antonio C P Chagas
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Visceral Fat Area and Serum Adiponectin Level Predict the Development of Metabolic Syndrome in a Community-Based Asymptomatic Population.

Authors:  Sang-A Cho; Hyung Joon Joo; Jae-Young Cho; Seung Hun Lee; Jae Hyoung Park; Soon Jun Hong; Cheol Woong Yu; Do-Sun Lim
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

7.  Intra-abdominal fat accumulation is a hypertension risk factor in young adulthood: A cross-sectional study.

Authors:  Atsushi Takeoka; Jun Tayama; Hironori Yamasaki; Masakazu Kobayashi; Sayaka Ogawa; Tatsuo Saigo; Hiroaki Kawano; Norio Abiru; Masaki Hayashida; Takahiro Maeda; Susumu Shirabe
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.